Psychiatric screening for migraine patients

被引:5
作者
Gambini, O. [1 ]
Biagianti, B. [1 ,2 ,3 ]
Grazzi, L. [4 ]
Usai, S. [4 ]
Scarone, S. [1 ]
Bussone, G. [4 ]
机构
[1] Univ Milan, AO San Paolo, Dipartimento Sci Salute, I-20142 Milan, Italy
[2] Univ Calif San Francisco, Dept Radiol, Biomagnat Imaging Lab, San Francisco, CA 94143 USA
[3] Vet Affairs Med Ctr, San Francisco Dept, Dept Psychiat, San Francisco, CA 94121 USA
[4] C Besta Neurol Inst & Fdn, Dept Clin Neurosci, Headache Unit, Milan, Italy
关键词
Migraine; Medication overuse; Psychiatric comorbidities; ASSESSMENT MIDAS QUESTIONNAIRE; MEDICATION-OVERUSE; CLINICAL-FEATURES; DEPENDENCE SCALE; HEADACHE; DISABILITY; SEVERITY; RELIABILITY; DYSFUNCTION; DEPRESSION;
D O I
10.1007/s10072-013-1359-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Psychiatric disorders in migraine patients have a higher prevalence than general population. The presence of psychiatric comorbidities may influence the complexity of the migraine pictures and be related to medication overuse. Severely impaired chronic migraineurs presenting with medication overuse are a challenge for headache clinics. Psychiatric comorbities, such as dependency-like behaviors, anxiety and mood symptoms, might account for headache-related disability and recurrent relapses into medication overuse after a successful detoxification. Within a sample of 63 chronic migraineurs with medication overuse and severe disability, we investigated to which extent clinical severity, affective states and attitudes about medication impact the overall functioning at time of detoxification. To unravel whether some of these factors could predict their long-term outcome, we followed and retest them 1 year after withdrawal. We hypothesized that the detoxification would have led to a partial improvement and not modified the attitudes toward medication and dependence. Detoxification improves most of the clinical and affective measures, but does not free from significant levels of pain intensity and headache-related disability. The partial benefit from detoxification, the severity bias and the maladaptive cognitive profile led us to believe that subgroups of chronic-relapsing migraineurs deserve a multidisciplinary approach that addresses not only the reduction of clinical severity but also specific cognitive and behavioral impairments.
引用
收藏
页码:S61 / S66
页数:6
相关论文
共 30 条
  • [1] Disability in chronic migraine with medication overuse: Treatment effects at 3 years
    Andrasik, Frank
    Grazzi, Licia
    Usai, Susanna
    D'Amico, Domenico
    Kass, Steven
    Bussone, Gennaro
    [J]. HEADACHE, 2007, 47 (09): : 1277 - 1281
  • [2] COGNITIVE FUNCTION IN MAJOR DEPRESSION
    AUSTIN, MP
    ROSS, M
    MURRAY, C
    OCARROLL, RE
    EBMEIER, KP
    GOODWIN, GM
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1992, 25 (01) : 21 - 29
  • [3] Orbitofrontal Dysfunction and Medication Overuse in Patients With Migraine
    Biagianti, Bruno
    Grazzi, Licia
    Gambini, Orsola
    Usai, Susanna
    Muffatti, Riccardo
    Scarone, Silvio
    Bussone, Gennaro
    [J]. HEADACHE, 2012, 52 (10): : 1511 - 1519
  • [4] Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes
    Bigal, ME
    Rapoport, AM
    Sheftell, FD
    Tepper, SJ
    Lipton, RB
    [J]. CEPHALALGIA, 2004, 24 (06) : 483 - 490
  • [5] Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy
    Boe, M. G.
    Salvesen, R.
    Mygland, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (06) : 705 - 712
  • [6] MIGRAINE AND MAJOR DEPRESSION - A LONGITUDINAL-STUDY
    BRESLAU, N
    DAVIS, GC
    SCHULTZ, LR
    PETERSON, EL
    [J]. HEADACHE, 1994, 34 (07): : 387 - 393
  • [7] The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version
    D'Amico, D
    Mosconi, P
    Genco, S
    Usai, S
    Prudenzano, AMP
    Grazzi, L
    Leone, M
    Puca, FM
    Bussone, G
    [J]. CEPHALALGIA, 2001, 21 (10) : 947 - 952
  • [8] Diener Hans-Christoph, 2010, Handb Clin Neurol, V97, P589, DOI 10.1016/S0072-9752(10)97051-6
  • [9] Clinical features, pathophysiology, and treatment of medication-overuse headache
    Evers, Stefan
    Marziniak, Martin
    [J]. LANCET NEUROLOGY, 2010, 9 (04) : 391 - 401
  • [10] Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine
    Fumal, A
    Laureys, S
    Di Clemente, L
    Boly, M
    Bohotin, V
    Vandenheede, M
    Coppola, G
    Salmon, E
    Kupers, R
    Schoenen, J
    [J]. BRAIN, 2006, 129 : 543 - 550